Neurons that produce dopamine are degraded in Parkinson’s disease. Although replacing dopamine can improve the resulting loss of motor function, such treatments can also produce involuntary movements, or dyskinesia.
Scientists in the journal PNAS investigated the molecular pathways that lead to this dyskinesia in an effort to ameliorate the condition. Because upregulating serotonin can reduce dyskinesia, the authors focused on p11, a cellular scaffold protein that increases the presence of certain serotonin receptors in the brain.
Using mice with brain lesions similar to those found in Parkinson’s disease, the authors injected small viral vectors encoding an RNA molecule that blocks p11 production in the dorsal striatum, a brain region that responds to dopamine.
Despite predictions that blocking p11 would worsen dyskinesia, the treatment improved motor function. When the mice were treated with dopamine, they showed reduced indicators of dyskinesia.
Because p11 is found throughout the brain, the authors note that systemic p11 blockade could produce side effects such as depression, but suggest that blocking p11 in the dorsal striatum alone may offer a potentially viable therapeutic strategy for Parkinson’s disease.
http://www.pnas.org/content/early/2016/01/13/1524387113
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Dual sensor role for potassium channel in bacteria!
Read more
Faster detection of pathogens in the lungs
Read more
Antibodies that are effective against both dengue and Zika viruses
Read more
$2 portable Zika test
Read more
A new angle for countering severe bacterial infections and sepsis
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar